108 related articles for article (PubMed ID: 2572319)
41. High-level expression of the ribosomal protein L19 in human breast tumors that overexpress erbB-2.
Henry JL; Coggin DL; King CR
Cancer Res; 1993 Mar; 53(6):1403-8. PubMed ID: 8095182
[TBL] [Abstract][Full Text] [Related]
42. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.
Huo L; Sugimura J; Tretiakova MS; Patton KT; Gupta R; Popov B; Laskin WB; Yeldandi A; Teh BT; Yang XJ
Hum Pathol; 2005 Mar; 36(3):262-8. PubMed ID: 15791570
[TBL] [Abstract][Full Text] [Related]
43. Localization of aberrant messenger RNA of epidermal growth factor receptor (EGFR) in malignant glioma.
Tsugu A; Kijima H; Yamazaki H; Ohnishi Y; Takamiya Y; Abe Y; Ueyama Y; Sato O; Tamaoki N; Nakamura M
Anticancer Res; 1997; 17(3C):2225-32. PubMed ID: 9216693
[TBL] [Abstract][Full Text] [Related]
44. In contrast to EGFr gene overexpression, H-ras gene expression decreases in human gliomas.
Blumenstock M; Prosenc N; Patt S; Pfanne K; Drum F; Cervos-Navarro J
Anticancer Res; 1991; 11(3):1353-7. PubMed ID: 1888172
[TBL] [Abstract][Full Text] [Related]
45. Preferential expression of the dbl protooncogene in some tumors of neuroectodermal origin.
de Franciscis V; Rosati R; Colucci-D'Amato GL; Eva A; Vecchio G
Cancer Res; 1991 Aug; 51(16):4234-7. PubMed ID: 1868443
[TBL] [Abstract][Full Text] [Related]
46. Expression of ERBB2 in human gastric carcinomas: relationship between p185ERBB2 expression and the gene amplification.
Kameda T; Yasui W; Yoshida K; Tsujino T; Nakayama H; Ito M; Ito H; Tahara E
Cancer Res; 1990 Dec; 50(24):8002-9. PubMed ID: 1979253
[TBL] [Abstract][Full Text] [Related]
47. Co-amplification of transcriptionally active epidermal growth factor receptor and ribosomal genes in the human hepatoma cell line Li7A.
Saint-Ruf C; Viegas-Péquignot E; Alfani E; Clementi M; Dutrillaux B; Carloni G
Oncogene; 1992 Aug; 7(8):1557-65. PubMed ID: 1321403
[TBL] [Abstract][Full Text] [Related]
48. Amplification of the HER-2/neu protooncogene in human endocrine tumors.
Evers BM; Rády PL; Tyring SK; Sanchez RL; Rajaraman S; Townsend CM; Thompson JC
Surgery; 1992 Aug; 112(2):211-7; discussion 217-8. PubMed ID: 1353638
[TBL] [Abstract][Full Text] [Related]
49. Implications of erbB-2 overexpression for basic science and clinical medicine.
King CR; Kraus MH; DiFiore PP; Paik S; Kasprzyk PG
Semin Cancer Biol; 1990 Oct; 1(5):329-37. PubMed ID: 2103506
[TBL] [Abstract][Full Text] [Related]
50. Concomitant overexpression of the EGFR and erbB-2 genes in renal cell carcinoma (RCC) is correlated with dedifferentiation and metastasis.
Stumm G; Eberwein S; Rostock-Wolf S; Stein H; Pomer S; Schlegel J; Waldherr R
Int J Cancer; 1996 Feb; 69(1):17-22. PubMed ID: 8600053
[TBL] [Abstract][Full Text] [Related]
51. Chromosomal assignment of five cancer-associated rat genes: two thyroid hormone receptor (ERBA) genes, two ERBB genes and the retinoblastoma gene.
Szpirer C; Szpirer J; Rivière M; Ingvarsson S; Vennström B; Islam MQ; Levan G
Oncogene; 1991 Aug; 6(8):1319-24. PubMed ID: 1679528
[TBL] [Abstract][Full Text] [Related]
52. Genetic alterations in c-erbB-2 protooncogene as prognostic markers in human primary breast tumors.
Nagai MA; Marques LA; Torloni H; Brentani MM
Oncology; 1993; 50(6):412-7. PubMed ID: 7901824
[TBL] [Abstract][Full Text] [Related]
53. [Proto-oncogene C-erbB-2 and human cancer].
Toyoshima K
Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):309-14. PubMed ID: 1968737
[TBL] [Abstract][Full Text] [Related]
54. Aberrant expression of the c-erbB-2/neu protooncogene in ovarian cancer.
Hung MC; Zhang X; Yan DH; Zhang HZ; He GP; Zhang TQ; Shi DR
Cancer Lett; 1992 Jan; 61(2):95-103. PubMed ID: 1346099
[TBL] [Abstract][Full Text] [Related]
55. Amplification and overexpression of the epidermal growth factor receptor gene in human renal-cell carcinoma.
Ishikawa J; Maeda S; Umezu K; Sugiyama T; Kamidono S
Int J Cancer; 1990 Jun; 45(6):1018-21. PubMed ID: 2351482
[TBL] [Abstract][Full Text] [Related]
56. Preliminary evaluation of HER-2/neu oncogene and epidermal growth factor receptor expression in normal and neoplastic human ovaries.
Mileo AM; Fanuele M; Battaglia F; Scambia G; Benedetti-Panici C; Mattei E; Mancuso S; Delpino A
Int J Biol Markers; 1992; 7(1):47-51. PubMed ID: 1349908
[TBL] [Abstract][Full Text] [Related]
57. Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors.
Kraus MH; Issing W; Miki T; Popescu NC; Aaronson SA
Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9193-7. PubMed ID: 2687875
[TBL] [Abstract][Full Text] [Related]
58. Competitive-differential polymerase chain reaction for gene dosage estimation of erbB-1 (egfr), erbB-2, and erbB-3 oncogenes.
Roetger A; Brandt B; Barnekow A
DNA Cell Biol; 1997 Apr; 16(4):443-8. PubMed ID: 9150431
[TBL] [Abstract][Full Text] [Related]
59. [Amplification and expression of oncogenes in human malignant tumors--organ or tissue specificity and prognosis].
Ueda M; Shimizu N; Abe O
Nihon Geka Gakkai Zasshi; 1989 Sep; 90(9):1579-81. PubMed ID: 2573817
[TBL] [Abstract][Full Text] [Related]
60. Structure and expression of c-erbB-2 and EGF receptor genes in inflammatory and non-inflammatory breast cancer: prognostic significance.
Guérin M; Gabillot M; Mathieu MC; Travagli JP; Spielmann M; Andrieu N; Riou G
Int J Cancer; 1989 Feb; 43(2):201-8. PubMed ID: 2563719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
